About
Profile
Headquarters
Intraday
High
-
Low
-
52-week
High
-
Low
-
PBLA
...
Available for logged in users only.
The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.
Contact us via Twitter if you are interested in trying it out.
- Panbela Therapeutics GAAP EPS of -$5.68 misses by $2.08
- Panbela Therapeutics regains compliance with Nasdaq rules after closing ~$15M offering
- Panbela stock nosedives ~40% on pricing stock and warrants offering
- Panbela's therapy for pancreatic cancer gets orphan drug status in EU
- Panbela Therapeutics to execute 1-for-40 reverse stock split
- Panbela surges 19% on starting phase II trial of CPP-1X-T for type I diabetes
- Panbela stock surges 20% as EMA panel backs granting orphan drug status to cancer drug
- Panbela Therapeutics GAAP EPS of -$0.21
- Panbela Therapeutics dips 24% on pricing $6M public offering
- Panbela Therapeutics GAAP EPS of -$1.51
- Panbela rises on positive data from mouse study of ovarian cancer therapy
- Panbela Therapeutics GAAP EPS of -$0.27
- Catalyst watch: Eyes on FOMC, OPEC meeting, jobs report and Dell
- Panbela Therapeutics GAAP EPS of -$0.26
- Panbela Therapeutics agrees to acquire Cancer Prevention Pharmaceuticals
- Panbela begins phase 2 study of SBP-101 combo to treat pancreatic cancer
- Panbela posts interim data from early-stage trial for pancreatic cancer therapy
- Panbela Therapeutics reports Q3 results
- Panbela Therapeutics reports Q2 results
- Ocuphire Pharma, Predictive Oncology leads healthcare gainers; Altimmune, electroCore among major losers
Date | Price | Open | High | Low | Vol | Change | ER | |||
---|---|---|---|---|---|---|---|---|---|---|
May 12 | 1.607 | 1.520 |
1.610
|
1.520
|
5.77K | -0.19% | ||||
May 11 | 1.610 | 1.640 |
1.782
|
1.510
|
19.56K | -2.42% | ||||
May 10 | 1.650 | 1.580 |
1.775
|
1.580
|
17.44K | 4.76% | ||||
May 9 | 1.575 | 1.790 |
1.790
|
1.560
|
2.79K | -4.83% | ||||
May 6 | 1.655 | 1.730 |
1.730
|
1.507
|
11.42K | -2.65% | ||||
May 5 | 1.700 | 1.710 |
1.845
|
1.700
|
20.21K | -2.86% | ||||
May 4 | 1.750 | 1.730 |
1.794
|
1.710
|
7.49K | 1.74% | ||||
May 3 | 1.720 | 1.760 |
1.760
|
1.720
|
57.52K | -4.44% | ||||
May 2 | 1.800 | 1.730 |
1.900
|
1.730
|
12.37K | 1.69% | ||||
Apr 29 | 1.770 | 1.750 |
1.770
|
1.750
|
7.93K | 2.31% | ||||
Apr 28 | 1.730 | 1.720 |
1.730
|
1.663
|
5.96K | 2.37% | ||||
Apr 27 | 1.690 | 1.790 |
1.847
|
1.665
|
9.89K | -6.11% | ||||
Apr 26 | 1.800 | 1.860 |
1.900
|
1.760
|
25.69K | 1.64% | ||||
Apr 25 | 1.771 | 1.770 |
1.936
|
1.690
|
11.48K | 1.20% | ||||
Apr 22 | 1.750 | 1.710 |
1.810
|
1.710
|
1.39K | 2.34% | ||||
Apr 21 | 1.710 | 1.870 |
1.880
|
1.620
|
17.34K | -7.62% | ||||
Apr 20 | 1.851 | 1.920 |
1.920
|
1.840
|
22.13K | -1.54% | ||||
Apr 19 | 1.880 | 1.920 |
1.957
|
1.823
|
2.45K | -1.21% | ||||
Apr 18 | 1.903 | 1.970 |
1.970
|
1.901
|
4.67K | -3.89% | ||||
Apr 14 | 1.980 | 1.770 |
2.074
|
1.770
|
4.07K | 10% | ||||
Apr 13 | 1.800 | 1.810 |
2.000
|
1.760
|
66.02K | 0% |